Brookfield Asset Management Inc. expects dividend of $ 0.13 (NYSE: BAM)


Brookfield Asset Management Inc. (NYSE: BAM) (TSE: BAM.A) declared a dividend on Wednesday, June 16 reports. Investors of record on Friday, June 18 will receive a dividend of 0.13 per share from the financial services provider on Monday, June 28. This represents a return of 1.04%. The ex-dividend date for this dividend is Thursday, June 17.

Brookfield Asset Management has decreased its dividend by 3.6% over the past three years and has increased its dividend annually for the past 1 consecutive year. Brookfield Asset Management has a payout ratio of 18.1%, which means its dividend is sufficiently covered by earnings.

BAM actions traded up $ 0.06 during the midday session Wednesday, reaching $ 50.15. The company had a trading volume of 5,291,363 shares, compared to an average volume of 2,573,447. The company has a quick ratio of 0.90, a current ratio of 1.07, and a leverage ratio of 1.15 . Brookfield Asset Management has a one-year low at $ 29.09 and a one-year high at $ 50.97. The company has a market cap of $ 79.11 billion, a P / E ratio of 59.93 and a beta of 1.26. The company’s 50-day moving average is $ 47.42.

Brookfield Asset Management (NYSE: BAM) (TSE: BAM.A) last released its quarterly results on Wednesday, May 12. The financial services provider reported EPS of $ 0.77 for the quarter, beating the Zacks’ consensus estimate by $ 0.44 by $ 0.33. Brookfield Asset Management had a net margin of 2.23% and a return on equity of 1.22%. The company posted revenue of $ 16.41 billion in the quarter, compared to analysts’ expectations of $ 10.89 billion. In the same quarter of the previous year, the company achieved EPS of $ 0.55. The quarterly turnover of the activity is down by 1.1% compared to the same quarter of last year.

A number of equity research analysts have recently weighed in on BAM stocks. Credit Suisse Group Downgraded Brookfield Asset Management Shares From “Outperforming” To “Neutral” Rating And Raised Its Share Price Target From $ 52.00 To $ 54.00 In Released Report Wednesday March 31. TheStreet upgraded Brookfield Asset Management shares from a “c +” rating to a “b-” rating in a report released on Tuesday, March 23. Zacks investment research upgraded Brookfield Asset Management shares from a “sell” rating to a “custody” rating in a report released on Monday, May 17. Deutsche Bank Aktiengesellschaft raised its price target for Brookfield Asset Management shares from $ 43.00 to $ 45 and assigned the company a “conservation” rating in a report released on Friday, April 9. Finally, JPMorgan Chase & Co. lowered its target price on Brookfield Asset Management shares from $ 57.00 to $ 55.00 and set an “overweight” rating for the company in a report released on Monday, March 22. . Three research analysts gave the stock a conservation rating, five gave the stock a buy rating, and two gave the stock a high buy rating. Brookfield Asset Management currently has an average rating of “Buy” and a consensus target price of $ 48.50.

About Brookfield Asset Management

Brookfield Asset Management is one of the world’s leading alternative asset managers and one of the largest investors in real assets. Our investments focus on real estate, renewable energy, infrastructure and private equity assets. Our goal is to generate attractive long-term risk-adjusted returns for the benefit of our clients and shareholders.

Featured article: how the purchase of a call option works

Dividend history for Brookfield Asset Management (NYSE: BAM)

This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured article: What is an EV stock?

7 health actions serving innovation in 2021

We all knew that traditional health services were disrupted in 2020. The patient-doctor relationship has gone virtual. During the first months of the pandemic, many people in need of elective surgeries simply did not have this option available to them. And even local pharmacies have taken on a new role in e-commerce as curbside pickup or home delivery of prescription drugs has become the norm.

It’s no surprise that healthcare stocks took a rough ride last year. Overall, the sector was down 11%, well below the S&P 500 which climbed more than 15%.

However, the market is always looking to the future with a particular eye on innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in advanced testing for drugs that can deliver groundbreaking results for conditions that continue to plague our world.

This is the object of this presentation. We have identified 7 healthcare actions that offer innovative ideas that will help achieve better patient outcomes. And in some cases, it will completely revolutionize medicine. These are also the stocks that analysts watch.

Consult the “7 healthcare stocks for innovation in 2021”.

Source link


About Author


Comments are closed.